세계의 헬스케어 데이터 상호운용성 시장 보고서(2025년)
Healthcare Data Interoperability Global Market Report 2025
상품코드 : 1825396
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헬스케어 데이터 상호운용성 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 16.2%로, 133억 6,000만 달러로 성장합니다. 예측 기간의 성장은 지속적인 규제 구상, 의료정보교환 기술의 발전, 원격의료 및 원격 모니터링의 확대, 인공지능 및 분석, 소비자 참여 강화, 가치 기반 진료 모델, 정밀의료의 상호 운용성, 경쟁 우위로서의 상호 운용성, 데이터 프라이버시 및 보안 문제, 세계 협력 및 표준의 조화 등에 기인할 것으로 보입니다. 데이터 프라이버시 및 보안에 대한 우려, 세계 협력과 표준의 조화에 기인한다고 볼 수 있습니다. 예측 기간의 주요 동향으로는 데이터 형식 및 프로토콜 표준화, 상호운용성 플랫폼의 발전, 의료정보교환(HIE) 확대, 원격의료 및 원격 모니터링의 상호운용성, 블록체인 및 분산원장 기술, 인공지능(AI) 및 머신러닝(ML) 적용, 환자 중심 데이터 교환, 집단건강관리, 상호운용성 거버넌스 및 정책 등이 있습니다.

향후 5년간 16.2%의 성장률 전망은 지난번 예측보다 0.7% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 네덜란드와 싱가포르에서 조달한 FHIR(Fast Healthcare Interoperability Resources) 기반 데이터 교환 플랫폼과 유니버설 헬스 레코드 시스템(Universal Health Record System)의 비용을 상승시켜 의료 연계 문제를 악화시키고, 의료정보교환 비용을 상승시켜 미국 의료 서비스 프로바이더에게 부담을 줄 수 있습니다. 의료정보교환 비용을 상승시킴으로써 미국의 의료 서비스 프로바이더에게 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

의료시설에서 전문 서비스 로봇 증가가 헬스케어 데이터 상호운용성 시장의 성장을 주도하고 있습니다. 예를 들어 2022년 10월 국제로봇연맹이 보고한 바와 같이, 자동화 헬스케어 솔루션이 눈에 띄게 급증했습니다. 의료시설의 전문 서비스 로봇 설치 대수는 14,800대에 달하고, 전년 대비 23% 증가한 것으로 나타났습니다. 이러한 추세는 의료 서비스 제공 및 관리 프로세스를 최적화하기 위한 기술 기반 툴에 대한 수요가 증가하고 있음을 의미합니다. 이러한 자동화 솔루션의 통합은 헬스케어 데이터 상호운용성의 중요성을 강조하며, 환자 정보의 원활한 교환과 활용을 촉진하고, 진료 제공 강화 및 임상 워크플로우를 간소화할 수 있도록 돕습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Healthcare data interoperability encompasses the seamless exchange, interpretation, and utilization of data across different healthcare systems, devices, and applications, irrespective of their platform or provider. This capability streamlines the sharing of patient information among various healthcare settings, enhancing care coordination, clinical decision-making, and patient outcomes.

In healthcare data interoperability, three main models are recognized: centralized, hybrid, and decentralized. Centralized interoperability involves the aggregation and management of healthcare data within a single, centralized location or system. This model can be implemented either as cloud-based or on-premises solutions and operates at various levels, including foundational, structural, and semantic. Centralized interoperability finds application across a range of healthcare functions such as diagnosis, treatment, and beyond, serving diverse end users including healthcare providers, payers, and pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The healthcare data interoperability market research report is one of a series of new reports from The Business Research Company that provides healthcare data interoperability market statistics, including healthcare data interoperability industry global market size, regional shares, competitors with a healthcare data interoperability market share, detailed healthcare data interoperability market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare data interoperability industry. This healthcare data interoperability market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare data interoperability market size has grown rapidly in recent years. It will grow from $6.23 billion in 2024 to $7.33 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to government regulations, advancements in technology, economic incentives, consumer demand, industry collaboration, patient safety, and quality improvement, value-based care initiatives, research and innovation, globalization of healthcare, and public health surveillance.

The healthcare data interoperability market size is expected to see rapid growth in the next few years. It will grow to $13.36 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to continued regulatory initiatives, advancements in health information exchange technologies, expansion of telehealth and remote monitoring, artificial intelligence and analytics, empowered consumer engagement, value-based care models, interoperability in precision medicine, interoperability as a competitive advantage, data privacy and security concerns, global collaboration and standards harmonization. Major trends in the forecast period include standardization of data formats and protocols, advancements in interoperability platforms, expansion of health information exchanges (HIEs), interoperability in telehealth and remote monitoring, blockchain and distributed ledger technologies, application of artificial intelligence (AI) and machine learning (ML), patient-centered data exchange, population health management, interoperability governance and policy.

The forecast of 16.2% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of Fast Healthcare Interoperability Resources(FHIR)-based data exchange platforms and universal health record systems sourced from the Netherlands and Singapore, exacerbating care coordination challenges and elevating health information exchange costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in professional service robots in healthcare facilities is driving the growth of the healthcare data interoperability market. For example, in October 2022 saw a notable surge in automated healthcare solutions, as reported by the International Federation of Robotics. The increase in professional service robots in healthcare facilities, reaching 14,800 installations, reflects a 23% rise from the previous year. This trend signifies a growing demand for technology-driven tools aimed at optimizing healthcare delivery and management processes. The integration of such automated solutions underscores the importance of healthcare data interoperability, facilitating seamless exchange and utilization of patient information to enhance care delivery and streamline clinical workflows.

Leading companies in the healthcare data interoperability market are creating innovative solutions, such as digital platforms, to gain a competitive advantage. Digital platforms are online systems or applications that enable interactions, transactions, and information sharing between users, including e-commerce sites, social media networks, and cloud-based service platforms. For example, in August 2023, KMS Healthcare, a US-based company, introduced the CONNECT interoperability solution, a platform aimed at simplifying data exchange between electronic health records (EHRs). This solution features configurable, pre-tested FHIR APIs and an HL7 conversion engine, which help healthcare organizations overcome interoperability challenges and streamline data integration. By offering quick access to major EHRs, the CONNECT platform enables developers to rapidly test and develop applications, greatly reducing the costs and complexities of creating individual sandbox connections.

In September 2023, Enovacom acquired NEHS Digital and Xperis, subsidiaries of MNH Group. This strategic acquisition bolstered Enovacom's presence in the digital healthcare landscape, expanding its portfolio of solutions and expertise. NEHS Digital and Xperis, renowned for their healthcare data interoperability solutions, complement Enovacom's offerings, particularly in areas such as medical imaging, telemedicine, e-health programs, and medical interpreting services. This consolidation strengthens Enovacom's position as a leader in delivering innovative solutions tailored to the evolving needs of the healthcare industry.

Major companies operating in the healthcare data interoperability market are Optum Inc., Oracle Corporation, Cognizant Technology Solutions, Koninklijke Philips NV, Wipro Limited, Epic Systems Corporation, Infor Inc., Virtusa Corp, Deevita LLC, Ciox Health, Veradigm LLC, ViSolve Inc., Change Healthcare, InterSystems Corporation, NextGen Healthcare Inc., eMids, Consensus Cloud Solutions Inc., Merative, Orion Health Group Limited, Teletracking Technologies, OSP Labs, Jitterbit, Nalashaa Solutions, Lyniate, MphRx, Onyx Technology LLC, iNTERFACEWARE Inc

North America was the largest region in the healthcare data interoperability market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare data interoperability market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the healthcare data interoperability market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The healthcare data interoperability market includes revenues earned by entities by providing services, such as data standardization, semantic interoperability, technical connectivity, and policy frameworks. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Data Interoperability Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare data interoperability market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for healthcare data interoperability ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare data interoperability market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Healthcare Data Interoperability Market Characteristics

3. Healthcare Data Interoperability Market Trends And Strategies

4. Healthcare Data Interoperability Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Healthcare Data Interoperability Growth Analysis And Strategic Analysis Framework

6. Healthcare Data Interoperability Market Segmentation

7. Healthcare Data Interoperability Market Regional And Country Analysis

8. Asia-Pacific Healthcare Data Interoperability Market

9. China Healthcare Data Interoperability Market

10. India Healthcare Data Interoperability Market

11. Japan Healthcare Data Interoperability Market

12. Australia Healthcare Data Interoperability Market

13. Indonesia Healthcare Data Interoperability Market

14. South Korea Healthcare Data Interoperability Market

15. Western Europe Healthcare Data Interoperability Market

16. UK Healthcare Data Interoperability Market

17. Germany Healthcare Data Interoperability Market

18. France Healthcare Data Interoperability Market

19. Italy Healthcare Data Interoperability Market

20. Spain Healthcare Data Interoperability Market

21. Eastern Europe Healthcare Data Interoperability Market

22. Russia Healthcare Data Interoperability Market

23. North America Healthcare Data Interoperability Market

24. USA Healthcare Data Interoperability Market

25. Canada Healthcare Data Interoperability Market

26. South America Healthcare Data Interoperability Market

27. Brazil Healthcare Data Interoperability Market

28. Middle East Healthcare Data Interoperability Market

29. Africa Healthcare Data Interoperability Market

30. Healthcare Data Interoperability Market Competitive Landscape And Company Profiles

31. Healthcare Data Interoperability Market Other Major And Innovative Companies

32. Global Healthcare Data Interoperability Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Data Interoperability Market

34. Recent Developments In The Healthcare Data Interoperability Market

35. Healthcare Data Interoperability Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기